SAPROPTERIN vs SATRALIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
SAPROPTERIN vs SATRALIZUMAB: Safety Overview
| Metric | SAPROPTERIN | SATRALIZUMAB |
|---|---|---|
| Total FAERS Reports | 5,539 | 219 |
| Deaths Reported | 60 | 16 |
| Death Rate | 1.1% | 7.3% |
| Hospitalizations | 339 | 108 |
| Average Patient Age | 23.3 yrs | 51.6 yrs |
| % Female Patients | 61.6% | 82.1% |
| FDA Approval Date | Apr 29, 2025 | N/A |
| Manufacturer | Dr. Reddys Laboratories Inc | Genentech, Inc. |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |